Post-graduation in Basic Sciences / Engineering / Pharmacy / Technology with 60% aggregate marks for GEN and 55% aggregate marks for SC/ST/OBC- NCL/PH candidates from a UGC recognized University/ Institute / Autonomous bodies.
Masters degree in Biochemistry / Biotechnology / Life Sciences. Identification and validation of early predictive biomarkers of acute kidney injury in patients with acute respiratory distress syndrome.
Ph.D. in (Pharmacy or Pharmacology) Or M.B.B.S / M.Pharm / Pharm.D / M. Sc in Medical Pharmacology / Master’s degree in Public Health from a recognized university/Institute with 60% marks and 1 year of research experience.